This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NCI Reports Third Quarter 2011 Financial And Operating Results

NCI, Inc. (NASDAQ:NCIT), a leading provider of information technology (IT), engineering, logistics, and professional services and solutions to U.S. Federal Government agencies, today announced financial and operating results for the third quarter ended September 30, 2011.

Third quarter revenue was at the low end of management’s guidance range issued last quarter, and diluted earnings per share, including acquisition-related costs, was slightly above the guidance range.

Third Quarter Fiscal Year 2011 Results:

For the third quarter of 2011, NCI reported revenue of $132.0 million compared with third quarter 2010 revenues of $168.8 million, a decrease of 21.8%. The year-over-year decrease in revenue was due to the previously disclosed winding down of non-core Base Realignment and Closure (BRAC)-related programs and a decline in U.S. Air Force’s Network Centric Solutions (NETCENTS) product orders, which collectively accounted for $42.2 million; lower revenues from the PEO Soldier program, which accounted for $4.6 million; and decreases in revenue attributable to completion of task orders awarded under several Government Wide Acquisition Contracts (GWAC) and Indefinite Delivery/Indefinite Quantity (ID/IQ) vehicles, which accounted for $6.3 million. The decrease in revenue was partially offset by revenue attributable to programs added through the acquisition of AdvanceMed, which was completed in April 2011.

Operating income for the third quarter of 2011 decreased by 35.9% from the third quarter of 2010. Operating income for the third quarter of 2011 was $6.4 million, or 4.9% of revenue, compared with $10.1 million, or 6.0% of revenue, for the third quarter ended September 30, 2010. Operating margin for the third quarter of 2011 declined as a result of lower total revenue compared with the same period in 2010; higher indirect support expenses; higher depreciation and amortization and acquisition costs resulting from the AdvanceMed acquisition; and reduced profitability on the PEO-Soldier cost-plus-fee bridge contract.

As expected and previously disclosed, non-core materials-related revenue associated with the BRAC and NETCENTS contracts contributed little to no operating margin in the third quarter of 2011. Excluding this BRAC and NETCENTS revenue and related costs, core operating margin was 5.0% and 7.3% for the third quarters of 2011 and 2010, respectively.

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs